These side effects have been notably milder as compared to an inhibitor of both bromodomains. An in depth molecular Investigation also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies present paradigms for long run clinical trials in AML, and https://cruzfhatb.madmouseblog.com/12525319/5-simple-statements-about-abbv-744-clinical-trial-phase-1-results-explained